DE:2VF0 Stock Latest News
Company AnnouncementsHemostemix Wins Bahamas Approval for VesCell Trial and Advances Financing, Manufacturing3w ago
Company AnnouncementsHemostemix Advances $1 Million Private Placement to Fund Stem Cell Therapy Commercialization1M ago
Company AnnouncementsHemostemix Raises CDN$322,250 in Second Tranche of Private Placement2M ago- Company AnnouncementsHemostemix Raises $784,000 to Advance Stem Cell Therapy Commercialization7M ago
Company AnnouncementsHemostemix Raises C$480,000 to Advance Stem Cell Therapy Commercialization10M ago
Company AnnouncementsHemostemix Grants Stock Options to Boost Growth10M agoCompany AnnouncementsHemostemix Highlights VesCell Success at DFCon 2025 and Secures New Funding11M ago
Company AnnouncementsHemostemix Closes $461,230 Private Placement to Boost Operations12M ago- Company AnnouncementsHemostemix Secures TSXV Approval for Debt Settlement1y ago
Company AnnouncementsHemostemix Announces Strategic Private Placement to Enhance Operations1y ago
Company AnnouncementsHemostemix Expands Private Placement to $3 Million1y ago
Company AnnouncementsHemostemix Advances with Successful Sale of Convertible Debentures1y agoCompany AnnouncementsHemostemix Secures $2.97 Million in Private Placement to Boost Operations1y ago
Company AnnouncementsHemostemix Secures $1.5 Million Lead Order and Repays Convertible Debenture1y ago- Company AnnouncementsHemostemix Secures $336,500 in Private Placement to Bolster Growth1y ago
- Company AnnouncementsHemostemix Raises $2.67M to Boost Stem Cell Research1y ago
Company AnnouncementsHemostemix Secures $1.8M in Private Placement1y ago
Company AnnouncementsHemostemix Launches $4M Financing for Stem Cell Therapy Growth2y ago